Based on sampling-time BMI, fasting insulin (FINS), HbA1c, uric acid, isoleucine, phenylalanine and threonine, we constructed a prognostic nomogram for pp-GDM risk assessment, which provides a visual tool for estimating the probability of abnormal postprandial glucose elevation (Figure 5). The gene discussed is INS; the disease is gestational diabetes.